Equities analysts expect Option Care Health (NASDAQ:OPCH) to announce ($0.03) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Option Care Health’s earnings. The highest EPS estimate is $0.02 and the lowest is ($0.05). Option Care Health reported earnings per share of ($0.04) in the same quarter last year, which suggests a positive year-over-year growth rate of 25%. The company is scheduled to report its next earnings results on Wednesday, November 4th.
According to Zacks, analysts expect that Option Care Health will report full year earnings of ($0.17) per share for the current year, with EPS estimates ranging from ($0.19) to ($0.16). For the next year, analysts forecast that the business will post earnings of $0.17 per share, with EPS estimates ranging from $0.00 to $0.29. Zacks’ EPS averages are an average based on a survey of analysts that follow Option Care Health.
Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.04). The business had revenue of $740.80 million during the quarter, compared to analysts’ expectations of $740.80 million. Option Care Health had a negative net margin of 3.10% and a negative return on equity of 4.05%. The company’s revenue for the quarter was up 49.0% on a year-over-year basis. During the same period in the previous year, the company earned ($0.14) EPS.
OPCH has been the topic of several research reports. Bank of America initiated coverage on shares of Option Care Health in a research report on Wednesday, June 24th. They set a “buy” rating and a $18.00 price objective on the stock. SunTrust Banks raised their target price on shares of Option Care Health from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Barrington Research increased their price target on shares of Option Care Health from $17.00 to $19.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Finally, Zacks Investment Research upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and set a $14.00 price objective for the company in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Option Care Health presently has an average rating of “Buy” and a consensus price target of $19.17.
Shares of OPCH traded up $0.23 during mid-day trading on Friday, reaching $11.20. The company’s stock had a trading volume of 8,040 shares, compared to its average volume of 494,152. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.62 and a quick ratio of 1.24. Option Care Health has a 12-month low of $5.74 and a 12-month high of $18.21. The company’s 50 day moving average is $11.69 and its 200 day moving average is $12.46. The stock has a market cap of $2.05 billion, a PE ratio of -21.73 and a beta of 1.20.
In other Option Care Health news, Director Timothy P. Sullivan sold 2,700,000 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $12.50, for a total transaction of $33,750,000.00. Following the sale, the director now owns 32,690 shares in the company, valued at approximately $408,625. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Timothy P. Sullivan sold 8,000,000 shares of the firm’s stock in a transaction on Friday, July 24th. The stock was sold at an average price of $12.50, for a total value of $100,000,000.00. Following the transaction, the director now directly owns 32,690 shares of the company’s stock, valued at approximately $408,625. The disclosure for this sale can be found here. Company insiders own 80.90% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of OPCH. Nuveen Asset Management LLC increased its stake in shares of Option Care Health by 31.2% during the 2nd quarter. Nuveen Asset Management LLC now owns 194,547 shares of the company’s stock valued at $2,701,000 after acquiring an additional 46,246 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Option Care Health by 9.0% during the second quarter. Charles Schwab Investment Management Inc. now owns 223,897 shares of the company’s stock worth $3,108,000 after acquiring an additional 18,500 shares during the period. California State Teachers Retirement System grew its holdings in shares of Option Care Health by 5.5% during the second quarter. California State Teachers Retirement System now owns 51,193 shares of the company’s stock valued at $711,000 after purchasing an additional 2,658 shares during the last quarter. Great West Life Assurance Co. Can acquired a new stake in shares of Option Care Health during the 2nd quarter worth approximately $31,000. Finally, Sei Investments Co. raised its position in shares of Option Care Health by 19.7% during the 2nd quarter. Sei Investments Co. now owns 328,449 shares of the company’s stock worth $4,559,000 after purchasing an additional 54,026 shares during the period. Institutional investors and hedge funds own 14.22% of the company’s stock.
Option Care Health Company Profile
Option Care Health, Inc provides independent home and alternate site infusion services in the United States. It serves patients with acute and chronic conditions. The company is based in Bannockburn, Illinois.
Featured Story: Rule of 72
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.